Furthermore, our results demonstrate a significant correlation between HOXB9 expression and CD276 expression in several cancers, including BLCA, CESC, COAD, GBM, KIRC, KIRP, LAML, LGG, LIHC, LUSC, MESO, OV, PCPG, TGCT, and UVM. Here, CD276 is linked to bladder transitional cell carcinoma.